Gene · 3817
Papers1,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Towards the identification of body fluids using RT-LAMP isothermal amplification coupled with CRISPR-Cas12a. | Forensic Sci Int Genet | 2025 | 39488143 | PubTator, text mining | PubMed |
| Exploring the Mechanisms Underlying Cellular Uptake and Activation of Dendritic Cells by the GK-1 Peptide. | ACS Omega | 2024 | 39713707 | PubTator, text mining | PubMed |
| Graph attention automatic encoder based on contrastive learning for domain recognition of spatial transcriptomics. | Commun Biol | 2024 | 39424696 | PubTator, text mining | PubMed |
| Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies. | Cancers (Basel) | 2024 | 39272956 | PubTator, text mining | PubMed |
| Extracellular Domain of IL-10 Receptor Chain-2 (IL-10R2) and Its Arginine-Containing Peptides Are Susceptible Substrates for Human Prostate Kallikrein-2 (KLK2). | Biochemistry | 2024 | 39106042 | PubTator, text mining | PubMed |
| Performance analysis of markers for prostate cell typing in single-cell data. | Genes Dis | 2024 | 39100200 | PubTator, text mining | PubMed |
| Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial. | J Clin Oncol | 2024 | 39038251 | PubTator, text mining | PubMed |
| A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer. | J Nucl Med | 2024 | 38782459 | PubTator, text mining | PubMed |
| Manzamine A reduces androgen receptor transcription and synthesis by blocking E2F8-DNA interactions and effectively inhibits prostate tumor growth in mice. | Mol Oncol | 2024 | 38605607 | PubTator, text mining | PubMed |
| Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2. | Int J Mol Sci | 2024 | 38396898 | PubTator, text mining | PubMed |
| KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation. | Biochem Genet | 2024 | 38316654 | PubTator, text mining | PubMed |
| Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinoma. | World J Clin Oncol | 2024 | 38292659 | PubTator, text mining | PubMed |
| Design of a novel analogue peptide with potent antibiofilm activities against Staphylococcus aureus based upon a sapecin B-derived peptide. | Sci Rep | 2024 | 38278972 | PubTator, text mining | PubMed |
| Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma. | BMC Pulm Med | 2024 | 38273291 | PubTator, text mining | PubMed |
| Creating cell-specific computational models of stem cell-derived cardiomyocytes using optical experiments. | bioRxiv | 2024 | 38260376 | PubTator, text mining | PubMed |
| Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach. | Biomolecules | 2024 | 38254687 | PubTator, text mining | PubMed |
| Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction. | Clin Transl Med | 2024 | 38239097 | PubTator, text mining | PubMed |
| Early detection of clinically significant prostate cancer: protocol summary and statistical analysis plan for the ProScreen randomised trial. | BMJ Open | 2024 | 38195170 | PubTator, text mining | PubMed |
| Bivalent activity of super-enhancer RNA LINC02454 controls 3D chromatin structure and regulates glioma sensitivity to temozolomide. | Cell Death Dis | 2024 | 38177123 | PubTator, text mining | PubMed |
| Utility of noninvasive biomarker testing and MRI to predict a prostate cancer diagnosis. | Int Urol Nephrol | 2024 | 37742327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3817/papers?page=3